| Paul Romain, | |
|
1493 Cambridge St, Cambridge, MA 02139-1047 | |
| (617) 665-1566 | |
| Not Available |
| Full Name | Paul Romain |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114086360 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 49004 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paul Romain, 1493 Cambridge St, Cambridge, MA 02139-1047 Ph: () - | Paul Romain, 1493 Cambridge St, Cambridge, MA 02139-1047 Ph: (617) 665-1566 |
News Archive
Kaiser Health News consumer columnist Michelle Andrews writes: "How much leeway do employers and insurers have in deciding whether they'll cover contraceptives without charge and in determining which methods make the cut? Not much, as it turns out, but that hasn't stopped some from trying. Kaiser Health News readers still write in regularly describing battles they're waging to get the birth control coverage they're entitled to" (Andrews, 8/22).
The European Union (EU) is in a state of flux following the recent accession of several Central and Eastern European countries. Their membership has further complicated the already complex economic, social and cultural dynamics at work within the EU.
Genentech, Inc. and XOMA Ltd. today announced preliminary results of a randomized, placebo-controlled Phase II study with RAPTIVA™ (efalizumab) in 107 patients with psoriatic arthritis. The study did not reach statistical significance at 12 weeks (84 days) for the primary endpoint, ACR 20 response. An ACR 20 response indicates at least a 20 percent improvement in an individual's signs and symptoms of arthritis.
A study published in the journal Royal Society Open Science demonstrates the critical role of timely intervention in New Zealand's success story. The researchers used a stochastic branching process model to simulate the trajectory of COVID-19 transmission and control during New Zealand's 2020 outbreak. They calculated the number of reported cases and deaths and the probability of elimination within a defined time frame.
Colon cancer is the second leading cause of cancer death in the United States and colonoscopy is the most-used screening tool to detect it.
› Verified 9 days ago
Yun- Ting Eric Yeh, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St Ste 310, Cambridge, MA 02138 Phone: 617-497-1560 Fax: 617-497-1190 | |
Dr. Catharine M. Mintzer, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 725 Concord Ave, Suite 4100, Cambridge, MA 02138 Phone: 617-864-8822 Fax: 617-547-5367 | |
Kenneth J. Gold, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 75 Mount Auburn St, Huhs, Cambridge, MA 02138 Phone: 617-495-8414 Fax: 617-496-0560 | |
Dr. Margaret Love Mclaughlin, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 515, Cambridge, MA 02138 Phone: 617-864-1571 Fax: 617-864-1507 | |
Dr. Valerie Pronio-stelluto, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5140 Fax: 617-499-5593 | |
Dr. Ayse A. Atasoylu, M.D., M.P.H. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 29 Everett St, Cambridge, MA 02138 Phone: 617-349-8222 | |
Dr. Alexandra Vania Chabrerie, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn Street, Department Of Medicine, Cambridge, MA 02138 Phone: 617-492-3500 |